Home
Controlled Release Delivery
3 April - 4 April 2017
Controlled Release Delivery

SAE Media Group is proud to announce the return of their 14th annual Controlled Release event to London in 2017!


A global pharmaceutical excipients market report states oral solid dosage formulations are expected to significantly increase uptake due to to the ease of consumption by patients globally. Oral application type segment is expected to increase from US$ 3,327.8 Mn in 2015 to US$ 5,094.2 Mn by the end of 2021.*

The prime drivers of the market will include increased demand for sustained-release and controlled-release formulations, especially in oral applications, and increased demand for generics. SAE Media Group’s Controlled Release 2017 event will guarantee practical and critical discussions on the latest innovation in controlled release drug delivery. The conference will strengthen understanding in the latest regulatory landscape.

* http://www.medgadget.com/2016/09/analyze-pharmaceutical-excipients-market-demands-by-2021.html

If you are a member of the Controlled Release Society and would like to claim your discount code, please forward your society email to zgale@SAE Media Group-online.co.uk to receive your voucher. 

FEATURED SPEAKERS

Mark Wilson

Mark Wilson

Director, Collaboration Management, Pharmaceutical Development Division, GlaxoSmithKline plc
Rene Holm

Rene Holm

Head and Scientific Director, Liquids & Parenterals, Janssen
Stephan Buchmann

Stephan Buchmann

Head Preformulation and Preclinical Galenics, Actelion Ltd.

Andrea Engel

Head of Particle Formulation Lab, Evonik
Andrea Engel

Damon Smith

CEO, Polymeric Particles & Altus Formulation
Damon Smith

David Elder

Constultant, David P Elder Consultancy
David Elder

Heiko Manninga

Managing Director, Co-Founder, NEUWAY Pharma GmbH
Heiko Manninga

Howard Stevens

Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde
Howard Stevens

Jim Jingjun Huang

Founder and CEO, Ascendia Pharmaceuticals LLC
Jim Jingjun  Huang

John Fox

Chief Development Officer, Merrion Pharmaceuticals
John Fox

Katerina Lalatsa

Lecturer in Pharmaceutics and Drug Delivery, University Of Portsmouth
Katerina Lalatsa

Liam Good

Director, Tecrea Ltd
Liam Good

Ludger Ickenstein

Associate Director – Delivery Technology, Boehringer Ingelheim Pharma GmbH & Co. KG
Ludger Ickenstein

Mark Wilson

Director, Collaboration Management, Pharmaceutical Development Division, GlaxoSmithKline plc
Mark Wilson

Parth Patwari

Founder & CSO, ProteoThera
Parth Patwari

Pranav Gupta

Prinicpal Scientist, Merck & Co Inc
Pranav Gupta

Rene Holm

Head and Scientific Director, Liquids & Parenterals, Janssen
Rene Holm

Rob Steendam

Chief Technology Officer, InnoCore Pharmaceuticals
Rob Steendam

Stephan Buchmann

Head Preformulation and Preclinical Galenics, Actelion Ltd.
Stephan Buchmann

sponsors

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Howard Stevens

Howard Stevens, Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde

clock

9:10

Lipid suspensions - how, when and with what?

Rene Holm

Rene Holm, Head and Scientific Director, Liquids & Parenterals, Janssen

• What is a lipid based suspension and how could it look from a commercialisation perspective?
• When can lipid based suspensions be used to improve the oral bioavailability?
• How large a proportion of the compound needs to be solubilised in the lipid phase?
• What excipients to use for lipid based formulation?
 

clock

9:50

Novel injectable formulations for postoperative pain with opioid sparing

Damon Smith

Damon Smith, CEO, Polymeric Particles & Altus Formulation

• NSAID analgesics administered concomitantly can greatly decrease opioid doses for effective analgesia (so-called opioid sparing) but in many cases they are poorly delivered.
• We are using our proprietary SmartCelle technology to develop a range of low volume, high concentration injectable NSAID and COX-II  products for the treatment of postoperative pain.
• Unlike today’s treatments which are quickly cleared from the body, the pharmacokinetics imparted by SmartCelle can maintain blood concentration of drug sufficiently to double exposure versus non-formulated drug.
 

clock

10:30

Morning Coffee

clock

11:00

Controlled erosion facilitates development of complex oral delivery profiles

Howard Stevens

Howard Stevens, Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde

• Therapeutic opportunities for Complex Oral Delivery Profiles?
• How to harness in-vivo erosion to achieve CODPs?
• In-vivo Evaluation of CODPs?
 

clock

11:40

From ideas to novel drug products - parenteral and oral controlled release drug delivery strategies

Andrea Engel

Andrea Engel, Head of Particle Formulation Lab, Evonik

• Controlled release formulation design, scale-up and GMP manufacturing of PLGA-based microparticles
• Multi-unit oral dosage form with EUDRATEC® PEP  for oral delivery of macromolecules and poorly permeable small drugs.
• Evonik platform technologies offer a combination of synergistic modules for improved bioavailability in combination with a tailored drug release profile
 

clock

12:20

Networking Lunch

clock

13:20

Parenteral delivery of nano-carriers

Jim Jingjun  Huang

Jim Jingjun Huang, Founder and CEO, Ascendia Pharmaceuticals LLC

clock

14:00

Delivery and release of small molecules and biologics using Nanocin technology

Liam Good

Liam Good, Director, Tecrea Ltd

• Nanocin™ forms nanoparticles on interaction with nucleic acids, proteins, peptides and small molecules
• The polymer has a low toxicity profile and a long history of safe use
• Nanocin™:drug particles and examples of cell entry and functional effects will be presented
 

clock

14:40

Afternoon Tea

clock

15:10

Examining how Quality by Design (QbD) can aid formulation and controlled release delivery

David Elder

David Elder, Constultant, David P Elder Consultancy

• Assessing the importance of QbD in controlled release delivery
• Implementation of QbD principles in the development of microsponges as drug delivery carriers
• The advantages of implementing QbD into controlled release systems
 

clock

15:50

Biodegradable polymeric microparticles and hydrogels for parenteral drug delivery

Rob Steendam

Rob Steendam, Chief Technology Officer, InnoCore Pharmaceuticals

- Whereas PLGA has its limitations for protein delivery causing e.g. burst, pH drop and instability, a different biodegradable polymer platform will be shared to solve the issues
* Demonstrating excellent control over release kinetics and effective preservation of protein bioactivity
* Several case studies will be presented to exhibit all requirements to develop sustained release formulations for parenteral delivery of biologic therapeutics.
 

clock

16:30

Chairman’s Closing Remarks and Close of Day One

Howard Stevens

Howard Stevens, Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Mark Wilson

Mark Wilson, Director, Collaboration Management, Pharmaceutical Development Division, GlaxoSmithKline plc

clock

9:10

The development and commercialisation of drug delivery systems: Challenges and opportunities

Mark Wilson

Mark Wilson, Director, Collaboration Management, Pharmaceutical Development Division, GlaxoSmithKline plc

• GSK’s experiences in developing technologies
• The collaborative “open innovation” approach
• Commercialisation challenges – finding the breakthrough application
• Examples of successful development and exploitation projects
• GSK’s approach to working with other organisations

 

clock

9:50

NEUWAY Pharma: Qualified for CNS drug delivery

Heiko Manninga

Heiko Manninga, Managing Director, Co-Founder, NEUWAY Pharma GmbH

• Treatment of CNS diseases is not limited by drugs, but by delivery.
• The majority of active substances is excluded from the CNS by the blood-brain-barrier
• NEUWAY is focusing on providing a gateway for drugs via this natural border
• NEUWAY’s engineered protein capsules (EPCs) consist of the natural VP1 protein of JV Virus - a virus that knows how to overcome the blood-brain barrier.
• EPCs are non-infectious and can be filled with a variety of therapeutic molecules
 

clock

10:30

Morning Coffee

clock

11:00

Matrix-binding fusions for local delivery of therapeutics

Parth Patwari

Parth Patwari, Founder & CSO, ProteoThera


--Challenges in delivery to tissues with dense matrix and poor vasculature
--Nature-inspired solutions using binding to matrix components
--Matrix-binding fusions for intra-articular delivery with extended retention


 

clock

11:40

Improving solubility and bioavailabilty

Stephan Buchmann

Stephan Buchmann, Head Preformulation and Preclinical Galenics, Actelion Ltd.

• Basic principles to be considered
• Opportunities and limitations to improve solubility and bioavailability
• Presentation of case studies
 

clock

12:20

Networking Lunch

clock

13:20

Hydrogel formulations for biologicals

Ludger Ickenstein

Ludger Ickenstein, Associate Director – Delivery Technology, Boehringer Ingelheim Pharma GmbH & Co. KG

clock

14:00

Formulation design & considerations for optimal drug product performance of oral controlled release systems

Pranav Gupta

Pranav Gupta, Prinicpal Scientist, Merck & Co Inc

 
• Drivers for CR Development & Oral CR Landscape over the past ten years
• Key considerations for CR technology selection, pre-clinical considerations for CR assessment
• Share case studies across different oral CR delivery systems highlighting critical formulation considerations to ensure optimal DP performance
• Discuss Emerging Areas/Technologies  for Oral CR Development
 

clock

14:40

Afternoon Tea

clock

15:10

Utilizing novel technology to accelerate drug development

John Fox

John Fox, Chief Development Officer, Merrion Pharmaceuticals

• Apply new technology to accelerate drug development pipeline and develop novel formulations
• Delivering benefit to the patient while creating novel formulations
• Translating the technology from use in R&D to clinical output
 

clock

15:50

The nanomedicine experience

Katerina Lalatsa

Katerina Lalatsa, Lecturer in Pharmaceutics and Drug Delivery, University Of Portsmouth

clock

16:30

Chairman’s Closing Remarks and Close of Day Two

Mark Wilson

Mark Wilson, Director, Collaboration Management, Pharmaceutical Development Division, GlaxoSmithKline plc


Head of Particle Formulation Lab
Evonik
CEO
Polymeric Particles & Altus Formulation
Constultant
David P Elder Consultancy
Managing Director, Co-Founder
NEUWAY Pharma GmbH
Assistant Head of Institute and Professor of Drug Delivery
University of Strathclyde
Founder and CEO
Ascendia Pharmaceuticals LLC
Chief Development Officer
Merrion Pharmaceuticals
Lecturer in Pharmaceutics and Drug Delivery
University Of Portsmouth
Director
Tecrea Ltd
Associate Director – Delivery Technology
Boehringer Ingelheim Pharma GmbH & Co. KG
Director, Collaboration Management, Pharmaceutical Development Division
GlaxoSmithKline plc
Founder & CSO
ProteoThera
Prinicpal Scientist
Merck & Co Inc
Head and Scientific Director, Liquids & Parenterals
Janssen
Chief Technology Officer
InnoCore Pharmaceuticals
Head Preformulation and Preclinical Galenics
Actelion Ltd.

Sponsors and Exhibitors

Official Media Partner

Official Publication

Supporters

Workshops

Challenges in inhaled drug delivery
Workshop

Challenges in inhaled drug delivery

Copthorne Tara Hotel
5 April 2017
London, United Kingdom

Preliminary List of Attending Organisations 2017

Download

Speaker Interview Series: Pranav Gupta, Principal Scientist, Merck & Co Inc

Download

Sponsor content: About DATA Detection Technologies

Download

Sponsor content: What our customers say about us

Download

Sponsor content: DATA COUNT PH-JR

Download

Sponsors and Exhibitors


Avanti Polar Lipids, Inc.

Sponsors and Exhibitors
http://www.avantilipids.com/

Avanti Polar Lipids, Inc. Since 1967 we have served the lipid community with the highest purity manufacturing, specialty products and lipid analysis. Avanti’s eight Divisions are concentrated in one central USA location: Research Products-Highest Purity Lipid Reagents cGMP Manufacturing- API & Contract Manufacturing Adjuvants-Vaccine Development Analytical Services-Lipid Analysis Lipidomics-MS Standards, Antibodies & Lipid Toolbox Formulations-Liposomes & Nanoparticles Equipment- Liposome Production Tools Custom Services-Synthesis & Beyond Avanti’s clients include Pharmaceutical Industries, Nutraceutical Industries and Lipid Researchers. How may we serve you?


Buchi

Sponsors and Exhibitors
http://www.buchi.co.uk/

For 75 years, BUCHI has been a leading solution provider in laboratory technology for R&D, quality control and production worldwide. We serve a wide range of industries such as pharmaceuticals, chemicals, food & beverage, feed, environmental analysis and academia.


DATA Detection Technologies

Sponsors and Exhibitors
http://www.data-technologies.com/ph_jr_count/

DATA Count PH JR quickly and accurately counts pharmaceutical pellets and mini tablets as small as 0.25mm providing for the first time a much needed tool to drug developers and manufacturers that produces capsules containing pellets. Based on DATA’s innovative electro optic counting technology this high-tech table-top counting machine is designed for High accuracy (99.95%), High speed and ease of use. The machine is simple to operate and is capable of storing and exporting data.


Precision NanoSystems

Sponsors and Exhibitors
http://www.precisionnanosystems.com/

Precision NanoSystems Inc (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.


Sirius Analytical

Sponsors and Exhibitors
http://www.sirius-analytical.com/

Sirius Analytical is a market leader in the fields of measurement of physicochemical properties, biorelevant solubility and dissolution and in vitro modelling of in vivo behaviour of formulated biological drugs. Our expertise areas include the delivery of oral, inhaled, injected and transdermal drugs. Sirius also offers analytical and consultancy services to help our customers solve all kinds of small and large molecule formulation challenges.

Media Partners


BioChem Adda

Official Media Partner
https://www.biochemadda.com/

BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


ONdrugDelivery Magazine

Official Media Partner
http://ondrugdelivery.com

ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.

Media Partners


International Journal of Biomedical Nanoscience and Nanotechnology

Official Publication
http://www.inderscience.com/ijbnn

IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.


International Journal of Computational Biology and Drug Design

Official Publication
http://www.inderscience.com/ijcbdd

IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


International Journal of Biotechnology

Official Publication
http://www.inderscience.com/ijbt

IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


International Journal of Nano and Biomaterials

Official Publication
http://www.inderscience.com/ijnbm

In recent years, frontiers of research in engineering, science and technology have been driven by developments in nanomaterials, encompassing a diverse range of disciplines such as materials science, biomedical engineering, nanomedicine and biology, manufacturing technology, biotechnology, nanotechnology, and nanoelectronics. IJNBM provides an interdisciplinary vehicle covering these fields. Advanced materials inspired by biological systems and processes are likely to influence the development of novel technologies for a wide variety of applications from vaccines to artificial tissues and organs to quantum computers.


International Journal of Nanoparticles

Official Publication
http://www.inderscience.com/ijnp

Nanoparticles are becoming key components in a wide range of applications. Research encompasses numerous disciplines, e.g. nanotechnology, molecular engineering, medicine, pharmaceutical drug manufacture, biology, chemistry, physics, optical components, polymer science, mechanical engineering, toxicology, cosmetics, energy, food technology and environmental and health sciences. IJNP highlights the chemical, physical and biological phenomena/processes associated with nanoparticles and nanostructures ranging from molecular size to 100nm which exhibit improved properties or have novel applications due to their size. Submicron nanoparticles are included in special cases.


International Journal of Nanotechnology

Official Publication
http://www.inderscience.com/ijnt

IJNT offers a multidisciplinary source of information in all subjects and topics related to Nanotechnology, with fundamental, technological, as well as societal and educational perspectives. Special issues are regularly devoted to research and development of nanotechnology in individual countries and on specific topics. Articles for IJNT are by invitation only.

Media Partners


GBI

Supporters
http://www.gbihealth.com/

GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


Technology Networks

Supporters
http://go.technologynetworks.com/subscribe-to-newsletters

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


International Pharmaceutical Industry

Supporters
http://www.ipimediaworld.com

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


Absave

Supporters
http://www.absave.com

Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


Pharmaceutical-Review

Supporters
http://www.pharmaceutical-review.com

Pharmaceutical-review.com is part of Integrated IQ technologies Private Limited(IIQ). A Leading platform for all the Pharma manufacturing companies and buyers across the world.Having a subscriber database of more than 120,000 globally helping the clients to reach their target buyers through our exclusive listing, branding(banner advertisement), e-news letters, e-mail marketing, product reviews, product launch promotions, event marketing, search engine marketing and social media marketing services.


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Contract Biotechnology

Supporters
http://www.contract-biotechnology.com

Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


Biosave

Supporters
http://www.Biosave.com

Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


Labsave

Supporters
http://www.labsave.com

Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


Select Science

Supporters
http://www.selectscience.net/

SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


Farmavita

Supporters
https://farmavitar.com

FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Drug Target Review

Supporters
http://www.drugtargetreview.com

Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.

Copthorne Tara Hotel

Scarsdale Place
Kensington
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.